# Pharmaids Pharmaceuticals Ltd (PHARMAID)
> Exchange: NSE | Sector: Pharma | ISIN: 

## Price
Current Price: ₹30.11
Day Change: -1.7%
52W High: ₹73.45
52W Low: ₹27.1
Market Cap: ₹106 Cr

## Valuation
P/E: 0
P/B: 2.06
EPS: ₹-5.12
Book Value: ₹14.65
Dividend Yield: 0%

## Returns
1Y Return: -54.36%

## Profitability
ROE: -137.5%
ROCE: 0%
Debt/Equity: 0
Revenue Growth: 0%
Profit Growth: 0%
EBITDA Margin: 0%
Operating Margin: 0%

## About
Pharmaids Pharmaceuticals Ltd is a Drug Manufacturers - Specialty & Generic company listed on BSE. The page combines exchange quotes, financial statements, shareholding, filings, and news so investors can review the business in one place.
Sector: Pharma
Industry: Drug Manufacturers - Specialty & Generic
Sub Industry: Unknown

## Business Model
Overview: Pharmaids Pharmaceuticals Ltd makes money through Domestic formulations, Exports and regulated markets, Specialty or institutional sales in Drug Manufacturers - Specialty & Generic. Revenue quality depends on demand growth, margin discipline, balance-sheet strength, and the company's ability to defend its position within Pharma.
Source: Derived from stock data
Revenue Streams:
- Domestic formulations
- Exports and regulated markets
- Specialty or institutional sales
Operating Model:
- Develops, manufactures, distributes, or services healthcare products across regulated channels.
- Approvals, product mix, compliance quality, and R&D productivity shape growth.
Recent Context:
- Announcement: Compliances-Reg.24(A)-Annual Secretarial Compliance
- Announcement: Announcement under Regulation 30 (LODR)-Newspaper Publication
- BSE Filing: Compliances-Reg.24(A)-Annual Secretarial Compliance

## Access
Current tier: anonymous
More history: Register free to see 7 more years.

## Data Freshness
Quote Updated: 2026-05-16T23:53:58.900Z
Price History Updated: 2026-05-19T01:02:27.942Z
Latest Price History Date: 2026-05-15
Technicals Updated: 2026-05-19T01:02:27.942Z
Quant Updated: 2026-05-19T01:02:27.942Z
Sentiment Updated: 2026-05-19T01:02:27.942Z
Financials Status: current
Financials Updated: 2026-05-18T13:30:00.909Z
Financials Last Attempt: 2026-05-18T13:30:00.909Z
Financials Provider Tried: database
Latest P&L Period: FY 2025
Latest Balance Sheet Period: FY 2025
Latest Cash Flow Period: FY 2025

## P&L (Mar 2015)
Revenue: ₹1 Cr
Operating Profit: ₹0 Cr (OPM -32%)
Net Profit: ₹0 Cr
Tax: ₹0 Cr

## Annual P&L History
Mar 2015: Rev ₹1Cr | PAT ₹0Cr | OPM -32%
Mar 2016: Rev ₹2Cr | PAT ₹0Cr | OPM -5%
Mar 2017: Rev ₹2Cr | PAT ₹0Cr | OPM -21%

## Balance Sheet (Mar 2015)
Total Assets: ₹3 Cr
Total Liabilities: ₹3 Cr
Borrowings: ₹0 Cr
Cash: ₹undefined Cr

## Shareholding
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%

---
Source: rupiya.io/stocks/pharmaid
Disclaimer: For research and education only. Not investment advice.